Most cited papers from PHV Dialysezentrum

PHV Dialysezentrum

What are the most cited papers from PHV Dialysezentrum?

The most cited paper from PHV Dialysezentrum is "The mortality risk of overhydration in haemodialysis patients" (V. Wizemann, Peter Wabel, Paul W. Chamney et al., 2009), with 640 citations. Next come "Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS" (556) and "Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy" (409).

Published TypeFieldAccessCitations

Showing 50 of 61 papers. Every paper with more than 65 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The mortality risk of overhydration in haemodialysis patients V. Wizemann, Peter Wabel, Paul W. Chamney et al. · Nephrology Dialysis Transplantation Open access	7 Jan 2009	640
2	Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS Rajiv Saran, J.L. Bragg-Gresham, Nathan W. Levin et al. · Kidney International Open access	Feb 2006	556
3	Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy V. Wizemann, Tong Lin, Sudtida S. Satayathum et al. · Kidney International Open access	6 Jan 2010	409
4	Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease Josef Leebmann, Eberhard Roeseler, Ulrich Julius et al. · Circulation Open access	21 Sep 2013	324
5	Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine Julian Stumpf et al. · The Lancet Regional Health - Europe Open access	23 Jul 2021	311
6	Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events Beate Roxane Jaeger, Yvonne Richter, Dorothea Nagel et al. · Nature Reviews Cardiology Review	23 Feb 2009	292
7	Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload Peter Wabel, Ulrich M Moissl, Paul W. Chamney et al. · Nephrology Dialysis Transplantation	3 Apr 2008	287
8	A phosphoserine/threonine‐binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation Morten Frödin, Torben L. Antal, Bettina A. Dümmler et al. · The EMBO Journal Open access	9 Oct 2002	276
9	Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry Jan Thomas Kielstein et al. · Nephrology Dialysis Transplantation	Oct 2012	239
10	The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients Martin Kimmel, Mark Dominik Alscher, Robert Dunst et al. · Nephrology Dialysis Transplantation	25 Oct 2005	233
11	Importance of normohydration for the long-term survival of haemodialysis patients Charles Chazot, Peter Wabel, Paul W. Chamney et al. · Nephrology Dialysis Transplantation	17 Jan 2012	225
12	Is the Frequency of Self-Monitoring of Blood Glucose Related to Long-Term Metabolic Control? Multicenter Analysis Including 24 500 Patients from 191 Centers in Germany and Austria Madeline Schutt, Werner Kern, Ulf von Krause et al. · Experimental and Clinical Endocrinology & Diabetes	16 Aug 2006	218
13	After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy Thomas Rauen et al. · Kidney International Open access	22 May 2020	213
14	Evolution of functional reorganization in hemiplegic stroke: A serial positron emission tomographic activation study Gereon Nelles, Gregor Spiekermann, Markus Jueptner et al. · Annals of Neurology	Dec 1999	194
15	A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study Holger Reinecke, Christiane M. Engelbertz, Rupert Martin Bauersachs et al. · Circulation Open access	6 Nov 2022	188
16	Cardiac Troponin T and I in End-Stage Renal Failure Diana Wayand, Hannsjörg H.E. Baum, Gabriele Schätzle et al. · Clinical Chemistry	Sep 2000	179
17	On‐line haemodiafiltration versus low‐flux haemodialysis. A prospective randomized study V. Wizemann, Christopher Lotz, Franz Techert et al. · Nephrology Dialysis Transplantation	Mar 2000	179
18	Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial Heiner H. Wedemeyer et al. · The Lancet Infectious Diseases	13 Sep 2022	165
19	Cerebrolysin and Recovery After Stroke (CARS) Dafin Fior Muresanu, Wolf‐Dieter Heiss, Volker Hoemberg et al. · Stroke Open access	12 Nov 2015	161
20	Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics Christoph Wanner, Vera Krane, Winfried März et al. · Kidney & Blood Pressure Research	2004	158
21	Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification Johann Braun, Hans-Gernot Asmus, H. Hölzer et al. · Clinical Nephrology	Aug 2004	149
22	Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study Jens Passauer, Hristo Petrov, Andreas Schleser et al. · Nephrology Dialysis Transplantation	6 Oct 2009	148
23	Decrease in Thoracic Vertebral Bone Attenuation With Calcium-Based Phosphate Binders in Hemodialysis Paolo Raggi, George James, Steven K. Burke et al. · Journal of Bone and Mineral Research	May 2005	145
24	Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients Helmut Schiffl · Nephrology Dialysis Transplantation	24 Sep 2002	144
25	MCO Membranes: Enhanced Selectivity in High-Flux Class Adriana Boschetti‐de‐Fierro, Manuel Voigt, Markus Storr et al. · Scientific Reports Open access	16 Dec 2015	143
26	Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate Alastair J Hutchison, Bart Maes, Johan Vanwalleghem et al. · Nephron Clinical Practice Open access	4 Apr 2005	143
27	Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis Joerg Plum, Stella Gentile, Christian Verger et al. · American Journal of Kidney Diseases	Apr 2002	142
28	Diuretic Use, Residual Renal Function, and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) Jennifer L. Bragg‐Gresham, Rachel B. Fissell, Nancy A. Mason et al. · American Journal of Kidney Diseases	Mar 2007	139
29	Detection limit of methods to assess fluid status changes in dialysis patients Matthias Kraemer, Christiane Rode, V. Wizemann · Kidney International Open access	24 Feb 2006	136
30	Effects of Smoking on Systemic and Intrarenal Hemodynamics Stephan Reinhold Orth · Journal of the American Society of Nephrology	2004	132
31	Significance of Interdialytic Weight Gain versus Chronic Volume Overload: Consensus Opinion Manfred Hecking, Angelo Karaboyas, Marlies Antlanger et al. · American Journal of Nephrology Open access	2013	131
32	Phosphate binder pill burden, patient‐reported non‐adherence, and mineral bone disorder markers: Findings from the DOPPS Rachel B. Fissell, Angelo Karaboyas, Brian A. Bieber et al. · Hemodialysis International Open access	14 May 2015	129
33	Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume? Cláudia Barth, Walther H. Boer, Daniela Garzoni et al. · Nephrology Dialysis Transplantation	13 Jun 2003	122
34	FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms Cynthia K. Brown, Horst Dieter Friedel, Amy R. Barker et al. · AAPS PharmSciTech Open access	Jun 2011	121
35	Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials Natan M. Bornstein, Alla B. Guekht, Johannes Vester et al. · Neurological Sciences ReviewOpen access	16 Dec 2017	118
36	Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies Joel Michels Topf, Thomas D. Wooldridge, Kieran McCafferty et al. · Kidney Medicine Open access	28 Jun 2022	117
37	Review Article: Cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: Grapefruit juice, St John's Wort – and beyond! (Review Article) Rainer Nowack · Nephrology Open access	19 Mar 2008	116
38	Frailty in hemodialysis and prediction of poor short-term outcome: mortality, hospitalization and visits to hospital emergency services César García-Cantón, Ana Belén Galera Ródenas, Celia Lopez-Aperador et al. · Renal Failure Open access	2019	106
39	Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany Hartmut P.H. Neumann et al. · Nephrology Dialysis Transplantation	8 Jan 2013	106
40	Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study Alastair J Hutchison, Bart Maes, Johan Vanwalleghem et al. · Nephron Clinical Practice Open access	14 Oct 2005	105
41	The rising tide of endstage renal failure from diabetic nephropathy type II—an epidemiological analysis Jörg Lippert, Eberhard Ritz, A Schwarzbeck et al. · Nephrology Dialysis Transplantation	Apr 1995	104
42	Von Hippel-Lindau Disease: Current Challenges and Future Prospects Sven Gläsker, Evelynn Vergauwen, Christian A. Koch et al. · OncoTargets and Therapy Open access	Jun 2020	101
43	Intermittent high permeability hemofiltration in septic patients with acute renal failure Stanislao Morgera, Jens Rocktäschel, Michael Haase et al. · Intensive Care Medicine	3 Sep 2003	101
44	Mutations in ACY1, the Gene Encoding Aminoacylase 1, Cause a Novel Inborn Error of Metabolism Jörn Oliver Sass, Verena Mohr, Heike Olbrich et al. · The American Journal of Human Genetics Open access	3 Feb 2006	96
45	LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood Thomas P. Bosch, Baerbel Schmidt, Werner Kleophas et al. · Artificial Organs	Sep 1997	95
46	A Critical Review of Sodium Profiling for Hemodialysis Siegfried Stiller, Edeltraud Bonnie‐Schorn, Aileen Grassmann et al. · Seminars in Dialysis	Sep 2001	93
47	Dilemma of assessing volume state—the use and the limitations of a clinical score V. Wizemann, Martin Karl Schilling · Nephrology Dialysis Transplantation	Nov 1995	84
48	Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis Alan Cass, Joan Cunningham, Zhiqiang Wang et al. · The Medical Journal of Australia	Aug 2002	81
49	ROUTINE IMMUNIZATIONS IN ADULT RENAL TRANSPLANT RECIPIENTS Daniela Huzly, Stefan Neifer, P. Reinke et al. · Transplantation	Mar 1997	79
50	Development and implementation of a comprehensive ultrasound curriculum for undergraduate medical students – a feasibility study C Nora, Jan Griewatz, Nisar P. Malek et al. · BMC Medical Education Open access	28 May 2019	75

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.